DOI: 10.1055/s-00035024

Thrombosis and Haemostasis

Accepted Manuscripts

Publication Date: 01 August 2022

Original Article

Bampatsias, Dimitrios; Mavroeidis, Ioannis; Tual-chalot, Simon; Vlachogiannis, Nikolaos L; Bonini, Francesca; Sachse, Marco; Mavraganis, Georgios; Mareti, Alexia; Kritsioti, Chrysoula; Laina, Ageliki; Delialis, Dimitris; Ciliberti, Giorgia; Sopova, Kateryna; Gatsiou, Aikaterini; Martelli, Fabio; Georgiopoulos, Georgios; Stellos, Konstantinos; Stamatelopoulos, Kimon: Beta-secretase-1 antisense RNA is associated with vascular ageing and atherosclerotic cardiovascular disease Beta-secretase-1 antisense in human atherosclerosis

Publication Date: 27 July 2022

Review Article

Yakovlev, Sergiy; Strickland, Dudley K; Medved, Leonid: Current View on the Molecular Mechanisms Underlying Fibrin(ogen)-Dependent Inflammation Fibrin(ogen)-dependent inflammation

Publication Date: 12 July 2022

Letters to the Editor

Publication Date: 11 July 2022

Original Article

Bourne, Joshua; Smith, Christopher; Jooss, Natalie; Di, Ying; Brown, Helena; Montague, Samantha; Thomas, Mark; Poulter, Natalie; Rayes, Julie; Watson, Steve P.: CLEC-2 supports platelet aggregation in mouse but not human blood at arterial shear CLEC-2 in platelet aggregation

Review Article

Brysland, Simone A; Maqbool, M Gohar; Talaulikar, Dipti; Gardiner, Elizabeth E: Bleeding propensity in Waldenström Macroglobulinaemia: Potential causes and evaluation Bleeding in Waldenström Macroglobulinaemia

Publication Date: 28 June 2022

Original Article

Kim, Sang-A; Lee, Ju Hyun; Lee, Ji Yun; Hwang, Hun-Gyu; Kim, Yang-Ki; Yhim, Ho-Young; Hong, Junshik; Lee, Jeong-Ok; Bang, Soo Mee: Treatment and bleeding complications of cancer-associated venous thromboembolism: A Korean population-based study Anticoagulation for cancer-associated thromboembolism

Publication Date: 10 June 2022

Original Article

Akyea, Ralph Kwame; Georgiopoulos, Georgios; Iyen, Barbara; Kai, Joe; Qureshi, Nadeem; Ntaios, George: Comparison of risk of serious cardiovascular events after haemorrhagic versus ischaemic stroke: a population-based study Cardiovascular risk after haemorrhagic versus ischemic stroke

Publication Date: 07 June 2022

Trial protocol design paper

Sedghi, Annahita; Heubner, Lars; Klimova, Anna; Tiebel, Oliver; Pietsch, Jörg; Mirus, Martin; Barlinn, Kristian; Minx, Tabea Tabita Talita Tatjana; Beyer-Westendorf, Jan; Puetz, Volker; Spieth, Peter; Siepmann, Timo: Point of Care Assessment of Direct Oral Anticoagulation in Acute Ischemic Stroke: Protocol for a Prospective Observational Diagnostic Accuracy Study PoC Anticoagulation Assessment in Stroke

Publication Date: 11 May 2022

Original Article

Nicol, Christophe; Ajzenberg, Nadine; Lacut, Karine; Couturaud, Francis; pan-petesch, brigitte; Lippert, Eric; Ianotto, Jean-Christophe: Hemorrhages in polycythemia vera and essential thrombocythemia: epidemiology, description, and risk factors, learnings from a large cohort. Hemorrhages in PV and ET

Publication Date: 10 February 2022

Original Article

Planquette, Benjamin; Khider, Lina; Le Berre, Alice; Soudet, Simon; Pernod, Gilles; Le Mao, Raphael; Besutti, Matthieu; Gendron, Nicolas; Yannoutsos, Alexandra; Smadja, David M; Goudot, Guillaume; Al Kahf, Salma; Mohammedi, Nassim; Al Hamoud, Antoine; Philippe, Aurélien; Fournier, Laure; Rance, Bastien; Diehl, Jean-Luc; Mirault, Tristan; Messas, Emmanuel; Emmerich, Joseph; Chocron, Richard; Couturaud, Francis; Ferreti, Gilbert; sevestre-pietri, marie-antoinette; meneveau, nicolas; Chatellier, Gilles; Sanchez, Olivier: Adjusting D-dimer to lung disease extent to exclude Pulmonary Embolism in COVID-19 patients (Co-LEAD)  According to Co-LEAD algorithm, the D-dimer level alone <900 ng/mL can safely exclude PE without CTPA among COVID-19 patients.  When D-dimer level is between 900 ng/mL and 1700 ng/mL, the severity of lung damage on CT scan (<50%, ≥50%) allows determining the need of a contrast agent injection to exclude PE.